Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small study met safety and performance goals.
Regulatory milestone paves the way for expanded access to Morphic’s non-implant, incisionless solution for treating acid reflux and related gastrointestinal disorders across Europe.
Mendaera has received FDA 510(k) clearance for its Focalist handheld robotic system, which enhances the precision of ultrasound-guided needle placement across multiple specialties.
FREMONT, Calif., July 8, 2025 /PRNewswire/ — Q’Apel Medical (Q’Apel), a private medical device company focused on revolutionizing neurovascular interventions, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its Zebra Neurovascular Access System. Available in 6F and 7F sizes, Zebra is indicated for the introduction of interventional devices into the peripheral and neurovasculature.
In combat zones and emergency rescues, rapid evacuation and treatment can mean the difference between life and death. But prolonged immobilization during transport poses another life-threatening risk: pressure injuries.
A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored.
For over a century, surgeons performing delicate procedures have relied on stereoscopic microscopes to gain a sense of depth. These tools mimic human vision by presenting slightly different images to each eye, allowing the brain to perceive three-dimensional structures—a crucial aid when working with fragile blood vessels or intricate brain tissue. Despite modern upgrades like digital displays and video capture, today’s operating microscopes still depend on the same core principle: two views, interpreted by the human brain.
In modern hospitals, timely and accurate decision-making is essential—especially in radiology, where contrast media consultations often require rapid answers rooted in complex clinical guidelines. Yet, physicians are frequently forced to make these decisions under pressure, without immediate access to all relevant information. This challenge is particularly critical for institutions that must also safeguard patient data by avoiding cloud-based tools.
In recent years, the analysis of single-cell and spatial data has revolutionized biomedical research, making it possible to observe what happens in biological samples with an unprecedented level of detail. Interpreting this data, however, is not easy because different software offers different results which are hard to compare.
A combination of high-resolution imaging and machine learning, also known as artificial intelligence (AI), can track cells damaged from injury, aging, or disease, and that no longer grow and reproduce normally, a new study shows.